Qiagen N.V.
- WKN: 901626
- ISIN: NL0000240000
- Land: Netherland
Nachricht vom 23.10.2012 | 15:38
QIAGEN N.V.: Release of a capital market information
QIAGEN N.V. / Share buyback
23.10.2012 15:38
Dissemination of a Post-admission Duties announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Disclosure according to Art. 4 Para. 4 of the Regulation (EC) No. 2273/2003
QIAGEN N.V. Share Repurchase -
Completion of first tranche
On September 21, 2012, QIAGEN N.V. disclosed pursuant to art. 4 para. 2 of
the Regulation (EC) no. 2273/2003 the beginning of the share buyback on
October 1, 2012. The first tranche of this program for the Euro-equivalent
amount of up to USD 10 million has been completed on October 18.
The total number of shares which have been bought back within the framework
of the share repurchase program in the time period from October 1, 2012
until and including October 18, 2012 amounts to 544,242 shares. The average
purchase price per share was EUR 14.2690; a total price of EUR 7,765,776.38
(excl. ancillary costs), which represents based on the ECB reference rate
as of October 1, 2012 an USD amount of 9,999,920.24, was paid to buy back
the shares.
The purchase of the shares of QIAGEN N.V. has been carried out by a
financial institution that has been commissioned by QIAGEN N.V.; the shares
are repurchased exclusively on the electronic trading platform of the
Frankfurt Stock Exchange (XETRA).
Further information regarding the transactions according to art. 4 para. 3
and 4 of the Regulation (EC) no. 2273/2003 is published on the website of
QIAGEN N.V. (www.qiagen.com).
We will report on the execution of further tranches of the buy-back program
in due course.
Venlo, 22 October 2012
The Managing Board
###
Contacts:
QIAGEN
Investor Relations
John Gilardi +49 2103 29 11711
Albert F. Fleury +1 240 686 7400
e-mail: ir@qiagen.com
Public Relations
Dr. Thomas Theuringer +49 2103 29 11826
e-mail: pr@qiagen.com
23.10.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: QIAGEN N.V.
Spoorstraat 50
5911 KJ Venlo
Netherlands
Internet: www.qiagen.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Anleihe im Fokus
Die DF-Anleihe 7,875%
Mit der DF Forfait AG vom wachsenden Welthandel profitieren
- Zeichnungsfrist: 21.05. bis 24.05.2013
- Laufzeit: 7 Jahre
- Kupon: 7,875% p.a.
- Volumen: bis zu 30 Mio. Euro
- ISIN: DE000A1R1CC4
Anleihe im Fokus
7,75% p.a. - Rendite aus Familienhand
– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs
GBC-Fokusbox
HELMA Eigenheimbau AG: Kaufen
Die HELMA Eigenheimbau AG präsentierte für das Geschäftsjahr 2012 Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen fairen Wert je Aktie von 22,75 € ermittelt. Ausgehend vom erwarteten 2013er-EPS von 1,64 € entspricht dies einem KGV von 8,4. Das Kurspotenzial beläuft sich auf nahezu 65%.
Der AKTIONÄR News

19. Mai 14:30 Investieren wie Warren Buffett: Verdienen Sie 4.809 Euro in den ...
19. Mai 10:30 Lufthansa und die Angst vor dem Streik
19. Mai 09:00 ThyssenKrupp: Es bleibt spannend
19. Mai 08:00 Die Prognosen der Profis
19. Mai 07:30 Talanx: Analysten heben den Daumen
News im Fokus
Fresenius Medical Care AG & Co. KGaA: Bekanntmachung nach Art. 4 Abs. 2 der Verordnung (EG) Nr. 2273/2003
17. Mai 2013, 17:35
Aktuelle Research-Studie
Original-Research: Plan Optik AG (von GBC AG): Kaufen Plan Optik AG
17. Mai 2013
